The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Aug 2017
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Rare cancers pose challenges for diagnosis, treatments, and clinical decision making. Information about rare cancers is scant. The RARECARE project defined rare cancers as those with an annual incidence of less than six per 100 000 people in European Union (EU). We updated the estimates of the burden of rare cancers in Europe, their time trends in incidence and survival, and provide information about centralisation of treatments in seven European countries. ⋯ The European Commission (Chafea).